Kidney Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older.
- People who have been diagnosed with a kidney tumor.
- People who had an MRI scan of the kidney taken before surgery, and that scan is available for review.
- People who have a matching pathology report that confirms the tumor type and, where relevant, its grade (how aggressive it appears under a microscope).
- People whose MRI images can be successfully retrieved and are clear enough to be used for image analysis.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom no MRI scan of the kidney is available.
- People who do not have a matching pathology report, or whose pathology report does not include enough detail about the tumor type or grade.
- People whose MRI images cannot be retrieved, opened, or read by the research team.
- People whose MRI images are of too poor a quality to be reliably reviewed or used in computer-assisted analysis.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 010-87787170
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accuracy of MRI-Based Artificial Intelligence for Pathological Subtyping of Renal Tumors; Accuracy of MRI-Based Artificial Intelligence for Histological Grading of Malignant Renal Tumors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.